Mutations in the ATRX gene were not identified; this gene is frequently mutated in other glioma subtypes including WHO grade II-III astrocytomas (71 %), oligoastrocytomas (68 %) and secondary glioblastomas (57 %) [2, 5]. This evidence concerns the gene ATRX and central nervous system cancer.